Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome

Background: In addition to surfactant deficiency, secretion of fluid from blood to the lungs and increase in the fluid content of the lung play significant roles in the pathogenesis of respiratory distress syndrome (RDS). Thus, we aimed to evaluate the effect of salbutamol (a beta-agonist) on fluid...

Full description

Bibliographic Details
Main Authors: Razieh Moazami Goudarzi, Zohreh Badiee, Alireza Sadeghnia, Behzad Barekatain
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2023;volume=28;issue=1;spage=53;epage=53;aulast=Moazami
_version_ 1797738556410560512
author Razieh Moazami Goudarzi
Zohreh Badiee
Alireza Sadeghnia
Behzad Barekatain
author_facet Razieh Moazami Goudarzi
Zohreh Badiee
Alireza Sadeghnia
Behzad Barekatain
author_sort Razieh Moazami Goudarzi
collection DOAJ
description Background: In addition to surfactant deficiency, secretion of fluid from blood to the lungs and increase in the fluid content of the lung play significant roles in the pathogenesis of respiratory distress syndrome (RDS). Thus, we aimed to evaluate the effect of salbutamol (a beta-agonist) on fluid clearance from the lungs in neonates with RDS. Materials and Methods: This randomized controlled clinical trial included 82 neonates with RDS admitted to the neonatal intensive care units of Alzahra and Shahid Beheshti Hospitals of Isfahan University of Medical Science from 2017 to 2018. Patients were recruited through convenience sampling. They were randomized into two groups, using simple randomization: 42 were only treated with intra-tracheal surfactant (control group) and 40 with intra-tracheal surfactant plus salbutamol (intervention group). The two groups were compared regarding intubation surfactant administration and extubation (INSURE) failure, duration of nasal continuous positive airway pressure, intubation, oxygen therapy, morbidity, and mortality. Results: INSURE failure leading to mechanical ventilation occurred in 3 neonates in the control group and 2 in the intervention group (P = 0.680). Mean hospital length of stay did not differ significantly between groups (P = 0.230). Comparison of controls with the intervention group regarding complications and the incidence of morbidities revealed no statistically significant difference (P > 0.05). Conclusion: Findings of this study were not in favor of the routine use of salbutamol in neonates with RDS as it did not improve the course of the disease among newborns.
first_indexed 2024-03-12T13:45:27Z
format Article
id doaj.art-d47031fb0c9f41e786a498055eed2a36
institution Directory Open Access Journal
issn 1735-1995
1735-7136
language English
last_indexed 2024-03-12T13:45:27Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Research in Medical Sciences
spelling doaj.art-d47031fb0c9f41e786a498055eed2a362023-08-23T09:43:20ZengWolters Kluwer Medknow PublicationsJournal of Research in Medical Sciences1735-19951735-71362023-01-01281535310.4103/jrms.jrms_548_22Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndromeRazieh Moazami GoudarziZohreh BadieeAlireza SadeghniaBehzad BarekatainBackground: In addition to surfactant deficiency, secretion of fluid from blood to the lungs and increase in the fluid content of the lung play significant roles in the pathogenesis of respiratory distress syndrome (RDS). Thus, we aimed to evaluate the effect of salbutamol (a beta-agonist) on fluid clearance from the lungs in neonates with RDS. Materials and Methods: This randomized controlled clinical trial included 82 neonates with RDS admitted to the neonatal intensive care units of Alzahra and Shahid Beheshti Hospitals of Isfahan University of Medical Science from 2017 to 2018. Patients were recruited through convenience sampling. They were randomized into two groups, using simple randomization: 42 were only treated with intra-tracheal surfactant (control group) and 40 with intra-tracheal surfactant plus salbutamol (intervention group). The two groups were compared regarding intubation surfactant administration and extubation (INSURE) failure, duration of nasal continuous positive airway pressure, intubation, oxygen therapy, morbidity, and mortality. Results: INSURE failure leading to mechanical ventilation occurred in 3 neonates in the control group and 2 in the intervention group (P = 0.680). Mean hospital length of stay did not differ significantly between groups (P = 0.230). Comparison of controls with the intervention group regarding complications and the incidence of morbidities revealed no statistically significant difference (P > 0.05). Conclusion: Findings of this study were not in favor of the routine use of salbutamol in neonates with RDS as it did not improve the course of the disease among newborns.http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2023;volume=28;issue=1;spage=53;epage=53;aulast=Moazamialbuterolnewbornprematurityrespiratory distress syndromesalbutamol
spellingShingle Razieh Moazami Goudarzi
Zohreh Badiee
Alireza Sadeghnia
Behzad Barekatain
Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome
Journal of Research in Medical Sciences
albuterol
newborn
prematurity
respiratory distress syndrome
salbutamol
title Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome
title_full Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome
title_fullStr Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome
title_full_unstemmed Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome
title_short Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome
title_sort evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome
topic albuterol
newborn
prematurity
respiratory distress syndrome
salbutamol
url http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2023;volume=28;issue=1;spage=53;epage=53;aulast=Moazami
work_keys_str_mv AT raziehmoazamigoudarzi evaluationofintratrachealsalbutamoleffectsinadditiontosurfactantintheclinicalcourseofprematureneonateswithrespiratorydistresssyndrome
AT zohrehbadiee evaluationofintratrachealsalbutamoleffectsinadditiontosurfactantintheclinicalcourseofprematureneonateswithrespiratorydistresssyndrome
AT alirezasadeghnia evaluationofintratrachealsalbutamoleffectsinadditiontosurfactantintheclinicalcourseofprematureneonateswithrespiratorydistresssyndrome
AT behzadbarekatain evaluationofintratrachealsalbutamoleffectsinadditiontosurfactantintheclinicalcourseofprematureneonateswithrespiratorydistresssyndrome